The objectives of this study were: (a) to explore the possibilities of developing a harmonized, pro-public health regional (Caribbean) IP regulation and drug policy (to include generic drugs) framework; (b) to make recommendations on the promulgation/up-dating of IP legislation and regulation...

This paper contributes to the literature on the impact of Big Science Centres on technological innovation. We exploit a unique dataset with information on CERN's procurement orders to study the collaborative innovation process between CERN and its industrial partners, mostly European firms....

Is work overload a friction to public agencies? Using data on R&D procurements, patents, and contracting units from a US federal agency, we investigate how officer workload impacts innovation procurement outcomes. Unanticipated retirement shifts provide an exogenous source of variation that we...

We analyze wartime prosthetic device patents to investigate how demand and procurement policy can shape medical innovation. We use machine learning tools to develop new data describing the aspects of medical and mechanical innovations that are emphasized in patent documents. Our analysis of...

Does workload constitute a bottleneck to a public agency’s mission, and if so, to what extent? We ask these questions in the context of the US government’s procurement of R&D. We link tender, contract, patent, and office records to the identity of the officer responsible for the procurement...

This Article is based on the 2021 Shidler Lecture, which was delivered at the University of Washington School of Law on November 4, 2021. Through enormous public support and private initiative, biopharmaceutical firms have developed safe and effective COVID-19 vaccines in record time. These...

We analyze wartime prosthetic device patents to investigate how demand and procurement policy can shape medical innovation. We use machine learning tools to develop new data describing the aspects of medical and mechanical innovations that are emphasized in patent documents. Our analysis of...

Ramp;D collaboration between firms and public research organizations (PROs) is considered a key component of national systems of innovation. A direct benefit from these collaborations is the production of new scientific and technological knowledge, which is disseminated essentially through...

This paper examines the effect of control rights over whether to publish or patent research results. University researchers have substantial discretion over disclosure, while management in non-academic organizations often direct researchers to patent their findings. Thus, the effect of control...

The empirical literature comparing the innovation performance of state-owned enterprises (SOEs) and private firms in China often yields conflicting results. To shed new light on this debate, we construct an extensive dataset by linking the Annual Survey of Industrial Enterprises (ASIE) dataset...